Value of 123I/99mTc-sestamibi parathyroid scintigraphy with subtraction SPECT/CT in primary hyperparathyroidism for directing minimally invasive parathyroidectomy
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 217 (1) , 108-113
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Dual-Isotope 99mTc-MIBI/123I Parathyroid Scintigraphy in Primary HyperparathyroidismClinical Nuclear Medicine, 2014
- Parathyroid Imaging: The Importance of Pinhole Collimation with Both Single- and Dual-Tracer AcquisitionJournal of Nuclear Medicine Technology, 2013
- Parathyroid ScintigraphyClinical Nuclear Medicine, 2012
- Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123IJournal of Nuclear Medicine Technology, 2012
- Case series of targeted parathyroidectomy with surgeon-performed ultrasonography as the only preoperative imaging studySurgery, 2011
- Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidismClinical Radiology, 2010
- National Trends in Parathyroid Surgery from 1998 to 2008: A Decade of ChangeJournal of the American College of Surgeons, 2009
- HyperparathyroidismThe Lancet, 2009
- Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid ScintigraphyJournal of Nuclear Medicine, 2007
- Use of surgeon-performed office ultrasound and parathyroid fine needle aspiration for complex parathyroid localizationSurgery, 2005